Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Editor's Note: We appreciate Dr Braunwald providing his professional and transparent explanation to clarify the differences in the reported financial disclosures among several of his recent publications in JAMA. We fully recognize that determining relevant financial relationships involves judgment and that reporting of financial disclosure information certainly is not an exact science. In fact, in one of the Commentaries1 that Dr Braunwald mentions, his co-author, Dr Gheorghiade, had reported to JAMA that he had received consulting fees from Bayer, Novartis, Sigma Tau, Johnson & Johnson, Takeda, Otsuka, and Medtronic. However, these disclosures inadvertently were omitted from the published article. The editors apologize for this oversight and regret this error. We urge all authors to fully disclose all possible conflicts of interest as recommended by the International Committee of Medical Journal Editors. A correction regarding the clarification of conflict of interest disclosures for Drs Braunwald and Gheorghiade appears in this issue.
Differences in an Author’s Conflict of Interest Disclosures—Reply. JAMA. 2012;307(6):561. doi:10.1001/jama.2012.111
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: